Avita Medical | 1811094D - 贸易债权人



金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 202.78M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


贸易债权人 更改 日
Accuray USD 43.52M 1.12M 2025-12
Celltrion KRW 88.58B 9.9B 2026-03
Clinuvel Pharmaceuticals AUD 10.68M 731.35K 2025-12
Cochlear AUD 281.3M 17.1M 2025-12
CSL USD 3.17B 290M 2025-12
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Deva Holding AS TRY 809.81M 105.88M 2023-09
Dianthus Therapeutics USD 6.39M 1.12M 2026-06
Divis Laboratories Ltd INR 12.11B 1.71B 2026-03
Kangmei Pharma CNY 2.46B 153.5M 2026-03
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Malin Corporation EUR 700K 200K 2024-12
Mayne Pharma AUD 30.25M 2.99M 2025-06
Medical Developments International AUD 4.31M 2.18M 2025-12
Nanosonics AUD 12.22M 10.69M 2025-12
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Organigram Holdings CAD 73.14M 2.06M 2026-03
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pacific Edge NZD 5.66M 212K 2026-06
Paradigm Biopharmaceuticals AUD 4.44M 1.71M 2025-12
Pharma Mar EUR 38.93M 4.9M 2026-06
Polynovo AUD 4.9M 2.04M 2025-12
PYC Therapeutics AUD 9.56M 802.76K 2025-12
Qiagen NV USD 78.3M 5.64M 2026-03
Ramsay Health Care AUD 2.02B 289.9M 2025-12
ResMed USD 273.3M 22.89M 2026-03
Sartorius EUR 329.1M 16.2M 2026-06
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
Telix Pharmaceuticals AUD 71.66M 19.98M 2025-12
Tilray USD 114.5M 3.69M 2025-09
Zealand Pharma A/S 171M 175.6M 2026-03
Zz Pientze Pharmaceu CNY 457.05M 59.09M 2026-03